Skip to content
Interagency Autism Coordinating Committee (IACC)
Autism Research Database
Office of Autism Research Coordination (OARC)
 
Project Element Element Description

Project Title

Project Title

5-Hydroxymethylcytocine-mediated epigenetic regulation in autism spectrum disorders

Principal Investigator

Principal Investigator

Jin, Peng

Description

Description

Autism spectrum disorders (ASD) includes an array of disorders including autism, Rett syndrome and fragile X syndrome. Accumulating evidence suggests a complex etiology for ASD that may include epigenetic and environmental factors. Epigenetics refer to inheritable changes not induced by DNA sequence alteration including DNA methylation, histone modification and non-coding RNA. DNA methylation has been proposed to play a role in autism. This hypothesis is supported by the discovery of the abnormal expression of MeCP2 in autism brain. In traditional concept, four different nucleotides exist in the genome: A, G, C, and T. Epigenetic studies have demonstrated that nucleotide C could be methylated (mC). Very recently, a novel DNA base 5-hydroxymethylcytosine (5-hmC) was discovered in mammalian brain and it constitutes a significant portion of nucleotides in the brain cells. These findings suggest 5-hmC modification might also be an important epigenetic modification. Hydroxylation of 5-mC to 5-hydroxymethylcytosine (5-hmC) presents a particularly intriguing epigenetic regulatory paradigm in mammalian brain, where its dynamic regulation is critical. The research team has established the technology to profile the genome-wide distribution of 5-hmC. Preliminary studies indicate that this particular DNA modification is widespread and could play significant roles in neurodevelopment. Given the neurodevelopmental phenotypes associated with ASD, it is important to evaluate its contribution to ASD pathogenesis. This Pilot project will investigate the potential involvement of 5-hmC in autism spectrum disorders. These studies will generate a large amount of data and could be shared with other investigators, and could contribute to the identification of autism genetic/epigenetic risk factors. This research will determine the role of 5-hydroxymethylcytosine-mediated epigenetic modulation in ASD. Two specific aims will be tested: Aim 1. To determine the genome-wide 5-hmC distribution profiles using multiple mouse models of Rett syndrome and human patients; Aim 2. To determine the genome-wide 5-hmC distribution profiles in both autistic and normal brains.

Funder

Funder

Autism Speaks

Fiscal Year Funding

Fiscal Year Funding

60000

Current Award Period

Current Award Period

2012-2014

Strategic Plan Question

Strategic Plan Question

Question 3: What Caused This To Happen And Can This Be Prevented?

Strategic Plan Objective

Strategic Plan Objective

Green dot: Objective has greater than or equal to the recommended funding. 3SJ. Support at least three studies that focus on the role of epigenetics in the etiology of ASD, including studies that include assays to measure DNA methylations and histone modifications and those exploring how exposures may act on maternal or paternal genomes via epigenetic mechanisms to alter gene expression, by 2012. IACC Recommended Budget: $20,000,000 over 5 years.

Project Link

Project Link

5-Hydroxymethylcytocine-mediated epigenetic regulation in autism spectrum disorders (External web link)

Institution

Institution

Emory University

State/Country

State/Country

Georgia

Project Number

Project Number

7660

Federal or Private?

Federal or Private?

Private

Received ARRA Funding?

Received ARRA Funding?

No

History/Related Projects

History/Related Projects

5-Hydroxymethylcytocine-mediated epigenetic regulation in autism spectrum disorders | 60000 | 2012 | 7660
5-Hydroxymethylcytocine-mediated epigenetic regulation in autism spectrum disorders | 0 | 2014 | 7660

 
Back to Top